Principal Consultant, Katie Herrick, shared an in-depth look at one of the most critical — and often overlooked — phases of a product's lifecycle: transitioning away from launch-phase affordability programs. This webinar explored post product launch in biopharma strategies for transitioning away from launch-phase affordability programs while maintaining long-term market access goals.

During the early stages of a launch, programs like QuickStart, Bridge, and Copay Vouchers are essential tools for overcoming limited payer coverage and driving early patient adherence. But as market access expands, manufacturers face a new and complex challenge — how to strategically phase out these introductory measures without disrupting patient care or undermining long-term access goals.

In this webinar, we moved beyond the why of implementation and focus on the how of sustainable transition, and offered actionable strategies for navigating this pivotal shift.

• Tuesday, June 16th
• 1:00 PM EST

Key Takeaways:

• The Launch Phase — Effective utilization of free trial and bridge programs during a pharma product launch to secure early adherence and build patient momentum..
• The Transition — Identifying the key trigger points that signal when it's time to shift away from launch-focused patient assistance.
• Best Practices — Proven approaches to minimize patient disruption while moving toward a sustainable, long-term access model.